Fred Alger Management, LLC T2 Biosystems, Inc. Transaction History

Fred Alger Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$0.58 - $3.01 $49,300 - $255,849	-85,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$2.56 - $4.48 $25,600 - $44,800	10,000 Added 13.33%	85,000 $224,000
Q4 2018 Feb 14, 2019	SELL	$2.98 - $6.86 $95,360 - $219,520	-32,000 Reduced 29.91%	75,000 $226,000
Q3 2018 Nov 14, 2018	BUY	$5.36 - $7.83 $10,720 - $15,660	2,000 Added 1.9%	107,000 $797,000
Q2 2018 Jul 19, 2018	BUY	$5.97 - $9.58 $626,850 - $1.01 Million	105,000 New	105,000 $813,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.